• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏超声检查在结构性异常和心律失常中的应用。识别与治疗。

Cardiac ultrasonography in structural abnormalities and arrhythmias. Recognition and treatment.

作者信息

Brook M M, Silverman N H, Villegas M

机构信息

Department of Pediatrics, UCSF School of Medicine 94143-0214.

出版信息

West J Med. 1993 Sep;159(3):286-300.

PMID:8236970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1011341/
Abstract

Fetal cardiac ultrasonography has become an important tool in the evaluation of fetuses at risk for cardiac anomalies. It can both guide prenatal treatment and assist the management and timing of delivery. We recommend that a fetal echocardiogram be done when there is a family history of congenital heart disease; maternal disease that may affect the fetus; a history of maternal drug use, either therapeutic or illegal; evidence of other fetal abnormalities; or evidence of fetal hydrops. The optimal timing of evaluation is 18 to 22 weeks' gestation. An entire range of structural cardiac defects can be visualized prenatally, including atrioventricular septal defect, ventricular septal defect, cardiomyopathy, ventricular outlet obstruction, and complex cardiac defects. The outcome for a fetus with a recognized abnormality is unfavourable, with less than 50% surviving the neonatal period. Fetal cardiac arrhythmias are also a common occurrence, 15% in the series described here. Premature atrial or ventricular contractions are most commonly seen and usually require no treatment. Supraventricular tachycardia can result in hydrops and require in utero treatment to prevent fetal demise. Complete heart block, particularly in association with structural heart disease, has a poor prognosis for fetal survival.

摘要

胎儿心脏超声检查已成为评估有心脏异常风险胎儿的重要工具。它既可以指导产前治疗,又有助于分娩的管理和时机选择。我们建议,当存在先天性心脏病家族史、可能影响胎儿的母体疾病、母体有治疗性或非法药物使用史、其他胎儿异常证据或胎儿水肿证据时,应进行胎儿超声心动图检查。最佳评估时机是妊娠18至22周。产前可以看到一系列结构性心脏缺陷,包括房室间隔缺损、室间隔缺损、心肌病、心室流出道梗阻和复杂心脏缺陷。已确诊异常的胎儿预后不佳,新生儿期存活率不到50%。胎儿心律失常也很常见,在此系列研究中占15%。最常见的是房性或室性早搏,通常无需治疗。室上性心动过速可导致水肿,需要宫内治疗以防止胎儿死亡。完全性心脏传导阻滞,尤其是与结构性心脏病相关时,胎儿存活预后不良。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/20109998d1d5/westjmed00073-0068-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/428871f85aef/westjmed00073-0056-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/526d2b971447/westjmed00073-0057-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/64e9cdb685f8/westjmed00073-0057-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/5511a1d8fafa/westjmed00073-0057-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/90bbc16830c9/westjmed00073-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/3e1350d85975/westjmed00073-0058-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/b51d2ec8f4a3/westjmed00073-0059-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/f510c588daab/westjmed00073-0059-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/933b38c2f4fd/westjmed00073-0060-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/645725b4fb5c/westjmed00073-0060-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/eeee74250611/westjmed00073-0060-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/7ad9e536fb15/westjmed00073-0061-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/ef154cb96ee5/westjmed00073-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/705eddc42c58/westjmed00073-0062-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/7d5fd177014d/westjmed00073-0062-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/fbc77fc40ecd/westjmed00073-0063-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/d7828cb38922/westjmed00073-0063-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/fd78c1a6bb7a/westjmed00073-0063-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/99760ac0fb8c/westjmed00073-0064-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/58784d062995/westjmed00073-0065-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/b79153eeb0ed/westjmed00073-0066-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/2e54f5c2e049/westjmed00073-0067-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/51041b490116/westjmed00073-0067-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/0be475da1450/westjmed00073-0067-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/20109998d1d5/westjmed00073-0068-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/428871f85aef/westjmed00073-0056-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/526d2b971447/westjmed00073-0057-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/64e9cdb685f8/westjmed00073-0057-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/5511a1d8fafa/westjmed00073-0057-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/90bbc16830c9/westjmed00073-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/3e1350d85975/westjmed00073-0058-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/b51d2ec8f4a3/westjmed00073-0059-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/f510c588daab/westjmed00073-0059-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/933b38c2f4fd/westjmed00073-0060-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/645725b4fb5c/westjmed00073-0060-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/eeee74250611/westjmed00073-0060-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/7ad9e536fb15/westjmed00073-0061-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/ef154cb96ee5/westjmed00073-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/705eddc42c58/westjmed00073-0062-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/7d5fd177014d/westjmed00073-0062-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/fbc77fc40ecd/westjmed00073-0063-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/d7828cb38922/westjmed00073-0063-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/fd78c1a6bb7a/westjmed00073-0063-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/99760ac0fb8c/westjmed00073-0064-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/58784d062995/westjmed00073-0065-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/b79153eeb0ed/westjmed00073-0066-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/2e54f5c2e049/westjmed00073-0067-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/51041b490116/westjmed00073-0067-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/0be475da1450/westjmed00073-0067-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2389/1011341/20109998d1d5/westjmed00073-0068-b.jpg

相似文献

1
Cardiac ultrasonography in structural abnormalities and arrhythmias. Recognition and treatment.心脏超声检查在结构性异常和心律失常中的应用。识别与治疗。
West J Med. 1993 Sep;159(3):286-300.
2
[Fetal echocardiography].[胎儿超声心动图]
Harefuah. 1991 Apr 15;120(8):431-5.
3
Outcome of fetuses with heart disease diagnosed in utero.产前诊断为心脏病的胎儿的结局。
Arch Dis Child Fetal Neonatal Ed. 1997 Jul;77(1):F41-6. doi: 10.1136/fn.77.1.f41.
4
Fetal echocardiography and congenital heart disease.胎儿超声心动图与先天性心脏病
Prof Care Mother Child. 2000;10(1):9-11.
5
Outcome for fetuses with prenatally detected congenital heart disease and cardiac arrhythmias in Taiwan.台湾地区产前检测出先天性心脏病和心律失常胎儿的结局。
J Formos Med Assoc. 2007 Jun;106(6):423-31. doi: 10.1016/S0929-6646(09)60291-6.
6
[Fetal echocardiography. The results of a 3-year study].[胎儿超声心动图。一项为期3年的研究结果]
Acta Med Port. 1993 Nov;6 Suppl 1:I9-13.
7
[Prenatal diagnosis of arrhythmias and associated congenital cardiac abnormalities using ultrasonography].[使用超声检查对心律失常及相关先天性心脏异常进行产前诊断]
Schweiz Med Wochenschr. 1993 Mar 27;123(12):537-41.
8
[Prenatal diagnosis of arrhythmias and conduction disturbances].[心律失常和传导障碍的产前诊断]
Ginekol Pol. 2004 Feb;75(2):124-7.
9
Type and significance of fetal arrhythmias.胎儿心律失常的类型及意义。
Indian Heart J. 1996 Jan-Feb;48(1):40-4.
10
Fetal echocardiography and fetal cardiology: indications, diagnosis and management.胎儿超声心动图与胎儿心脏病学:适应证、诊断与管理
Semin Perinatol. 1993 Apr;17(2):76-88.

引用本文的文献

1
Fetal Atrial Ectopic Rhythm Detected Using Handheld Doppler.使用手持多普勒检测胎儿房性异位心律。
Malays Fam Physician. 2020 Mar 18;15(1):50-53. eCollection 2020.
2
Diagnosis and management of non-immune hydrops in the newborn.新生儿非免疫性水肿的诊断与处理
Arch Dis Child Fetal Neonatal Ed. 1994 Sep;71(2):F149-50. doi: 10.1136/fn.71.2.f149-b.

本文引用的文献

1
Echocardiographic and anatomical correlates in the fetus.胎儿的超声心动图与解剖学关联
Br Heart J. 1980 Oct;44(4):444-51. doi: 10.1136/hrt.44.4.444.
2
Qualitative real-time cross-sectional echocardiographic imaging of the human fetus during the second half of pregnancy.妊娠后半期人类胎儿的定性实时横断面超声心动图成像。
Circulation. 1980 Oct;62(4):799-806. doi: 10.1161/01.cir.62.4.799.
3
Quantitative real-time cross-sectional echocardiography in the developing normal humam fetus and newborn.发育中正常人类胎儿和新生儿的定量实时横断面超声心动图
Circulation. 1980 Sep;62(3):588-97. doi: 10.1161/01.cir.62.3.588.
4
Identification of congenital cardiac malformations by echocardiography in midtrimester fetus.孕中期胎儿先天性心脏畸形的超声心动图诊断
Br Heart J. 1981 Oct;46(4):358-62. doi: 10.1136/hrt.46.4.358.
5
Fetal ascites associated with congenital heart disease. Case report.先天性心脏病伴胎儿腹水。病例报告。
Br J Obstet Gynaecol. 1981 Apr;88(4):453-5. doi: 10.1111/j.1471-0528.1981.tb01013.x.
6
Transplacental cardioversion of fetal supraventricular tachycardia with procainamide.用普鲁卡因胺经胎盘对胎儿室上性心动过速进行心脏复律。
N Engl J Med. 1982 Oct 28;307(18):1128-31. doi: 10.1056/NEJM198210283071806.
7
Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease.接受和未接受先天性心脏病手术治疗的女性的妊娠情况及其结局。
Am J Cardiol. 1982 Sep;50(3):641-51. doi: 10.1016/0002-9149(82)90334-4.
8
M-mode echocardiography in the developing human fetus.发育中的人类胎儿的M型超声心动图
Br Heart J. 1982 Jun;47(6):573-83. doi: 10.1136/hrt.47.6.573.
9
Fetal echocardiography for evaluation of in utero congestive heart failure.用于评估宫内充血性心力衰竭的胎儿超声心动图检查。
N Engl J Med. 1982 Mar 11;306(10):568-75. doi: 10.1056/NEJM198203113061003.
10
Intrauterine cardiothoracic surgery: the fetal lamb model.宫内心胸外科手术:胎羊模型
Ann Thorac Surg. 1982 Oct;34(4):422-6. doi: 10.1016/s0003-4975(10)61404-x.